Originally published In Press as doi:10.1074/jbc.M208558200 on September 13, 2002
J. Biol. Chem., Vol. 277, Issue 47, 44613-44622, November 22, 2002
The Kruppel-like Factor Zf9 and Proteins in the Sp1 Family
Regulate the Expression of HSP47, a Collagen-specific Molecular
Chaperone*
Kunihiko
Yasuda
,
Kazunori
Hirayoshi§,
Hiromi
Hirata¶,
Hiroshi
Kubota
,
Nobuko
Hosokawa
, and
Kazuhiro
Nagata
From the
Department of Molecular and
Cellular Biology, Institute for Frontier Medical Sciences, Kyoto
University, Sakyo-ku, Kyoto 606-8397, Japan and Core Research for
Evolutional Science and Technology, JST, Japan, the
§ Department of Ultrastructural Research, Institute for
Frontier Medical Sciences, Sakyo-ku, Kyoto University, Kyoto
606-8397, Japan, and the ¶ Institute for Virus Research, Kyoto
University, Kyoto 606-5807, Japan
Received for publication, August 21, 2002
 |
ABSTRACT |
In several cells and tissues the synthesis
of HSP47, a collagen-specific molecular chaperone in the endoplasmic
reticulum, is closely correlated with the synthesis of collagen. We
previously reported that the Sp1 binding site at
210 bp in the
promoter region and the first and second introns are required for the
tissue-specific expression of HSP47 in transgenic mice (Hirata, H.,
Yamamura, I., Yasuda, K., Kobayashi, A., Tada, N., Suzuki, M.,
Hirayoshi, K., Hosokawa, N., and Nagata, K. (1999) J. Biol.
Chem. 274, 35703-35710). Here, we analyze how these introns
influence the transcriptional regulation of the hsp47 gene
in BALB/c 3T3 cells, which produce high levels of HSP47. In
vitro promoter analysis using a luciferase reporter and gel
mobility shift analysis revealed that two cis-acting elements in the first and second introns, BS5-B and EP7-D,
respectively, are required for the activation of hsp47 in
BALB/c 3T3 cells. Several members of the Kruppel-like factor (KLF)
family of proteins were identified as BS5-B-binding proteins by yeast
one-hybrid analysis using these elements as baits. One of these
proteins, KLF-6/Zf9, binds to the BS5-B element and activates
expression of the reporter construct when transfected into cells.
Chromatin immunoprecipitation assay analysis revealed that the
endogenous KLF-6/Zf9 binds the BS5-B elements that contain the
CACCC motif, which is a consensus recognition sequence for other
proteins in the KLF family. We also showed that BS5-B and EP7-D are
bound by two members of the Sp1 family, Sp2 and Sp3. These results
suggest that at least three sequences are required for the constitutive expression of hsp47 in BALB/c 3T3 cells: the
210 bp Sp1
binding site, the BS5-B element in the first intron, and the EP7-D
element in the second intron. We suggest that KLF proteins regulate the transcription of hsp47 by binding the BS5-B element in
cooperation with Sp2 and/or Sp3.
 |
INTRODUCTION |
HSP47 is an endoplasmic reticulum (ER) resident stress-protein
that transiently binds to newly synthesized procollagen. It belongs to
the serpin (serine protease inhibitor) superfamily but is not secreted
because it contains the ER1
retention signal (RDEL) at the C terminus (1). HSP47 associates with
procollagen during its assembly, folding, and/or post-translational modification in the ER and dissociates from it in the ERGIC (ER-Golgi intermediate compartment) or in the cis-Golgi (2).
Biochemical studies using synthetic model peptides of collagen have
revealed that HSP47 preferentially binds to Gly-Xaa-Arg triplets
in the procollagen triple helical region (3). Recent studies have shown
that HSP47 plays a crucial role in collagen biosynthesis as a
collagen-specific molecular chaperone; hsp47 null mice
cannot synthesize collagen normally and cannot survive beyond the E11.5 stage of embryogenesis (4). These mice exhibit severe impairments in
the processing of the collagen N- and C-propeptides and in type I
procollagen triple helix formation, resulting in the absence of
collagen fibrils in mesenchymal tissues and basement membranes that lie
between the epithelial cell layer and the mesenchyme.
All known ER-localized stress proteins in mammalian cells are induced
by various ER stresses through the unfolded protein response
pathway (5). HSP47 is the only heat shock protein that resides in the
ER of mammalian cells that is induced by cytosolic stresses, including
heat shock, but it is not induced by ER stress (6). This induction
depends on the presence of the heat shock element in the
hsp47 promoter (7). On the other hand, the constitutive expression of hsp47 appears to be co-regulated with that of
several types of collagens. For example, during the differentiation of mouse F9 teratocarcinoma cells the rates of synthesis of HSP47 and type
IV collagen coordinately increase (8), and following the malignant
transformation of fibroblasts the rates of synthesis of the two
proteins, HSP47 and type I collagen, decrease (9). Collagen
nonproducing cells such as mouse myeloid leukemia M1 cells and rat
pheochromocytoma PC12 cells do not synthesize HSP47. The
spatiotemporally concerted expression of HSP47 with collagens is also
observed during mouse and chick embryonic development (10). In
addition, a marked induction of HSP47 has been reported in the
progression of fibrosis in various experimental fibrosis models,
including liver cirrhosis (11), kidney fibrosis (12), and
atherosclerosis (13). The down-regulation of hsp47 caused by
introducing hsp47 antisense oligoribonucleotides into rat
renal cells after the initiation of fibrosis markedly reduces the rate of the progression of fibrosis and reduces the levels of types I and
III collagens in the kidney (14).
In a previous paper (15), we demonstrated that both the 280-bp promoter
region and the first and second introns are required for the
tissue-specific expression of HSP47 in transgenic mice harboring a
-galactosidase reporter gene under the control of these elements.
In vitro promoter analysis using a luciferase reporter gene
revealed that the Sp1 binding site at
210 bp is necessary for the
basal expression of hsp47, and the addition of a downstream
intron region caused a marked up-regulation of reporter activity in
HSP47- and collagen-producing cells but not in nonproducing cells. In
this paper, we have further analyzed the cis-acting elements
in the intron regions that are responsible for the activation of
hsp47 expression, and we identify two such elements in the
first and second introns. We also used a yeast one-hybrid assay, gel
mobility shift analysis, and CHIP analysis to identify the
transcription factors that bind these elements. In addition to the
Kruppel-like factor (KLF) proteins, which were identified in the yeast
one-hybrid screen, we found that the Sp1 family proteins Sp2 and Sp3
are also involved in the regulation of hsp47 expression.
Among the KLF proteins, we further focused on the KLF-6/Zf9
protein in the activation of hsp47, as shown by gel mobility
shift analysis and reporter analysis of cells transfected with
Zf9 cDNA.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture and Transient Transfection Assays--
Murine
BALB/c 3T3 fibroblasts were cultured in Dulbecco's modified Eagle's
medium (with low glucose) (Invitrogen Corp., Carlsbad, CA) supplemented
with 10% fetal bovine serum at 37 °C in a 5% CO2 atmosphere.
DNA was transfected into BALB/c 3T3 cells using FuGENE 6 (Roche
Molecular Biochemicals, Mannheim, Germany) according to the manufacturer's instructions. BALB/c 3T3 cells were plated at a density
of 5 × 104 cells in 35-mm culture dishes 16 h
before transfection. Cells were harvested 48 h after transfection,
and luciferase activities were measured by using a luciferase reporter
assay system (Promega, Madison, WI). The plasmid
pact-
-galactosidase, which bears the chicken
-actin promoter
upstream of lacZ, was used as an internal control to normalize
transfection efficiency.
-Galactosidase assays were performed as
described previously (15).
Plasmids--
To make the BS-5 and BS5-B mutant constructs,
which have deletions within the first intron of the hsp47
gene, two sets of primers were designed. For the BS-5 deletion
(pLuc
BS-5), HSP47/BS-S (5'-TGGCCGGACTTGACCAATTA-3') and dBS5-S
(5'-CGGAATTCACCAAAGCCCCCAGTTTTCC-3') were used to amplify the 5' end of
the fragment. Primers HSP47/BS-AS (5'-CACTTGGTGGGGTCTAAAGA-3') and
dBS5-AS/2 (5'-CGGAATTCCGAGGTGTTTTTGTAGTGGG-3') were used to amplify the
3' end of the fragment. The two PCR products were ligated into
BstX1-SfiI-digested pLuc280(III). Primers dBS5B-S (5'-CGGAATTCCCTTACTTCCAGGCAACCAA-3') and dBS5B-AS
(5'-CGGAATTCTGTACCCATCCCCCATTTCC-3') were used instead of dBS5-S
and dBS5-AS/2 to construct pLuc
BS5-B. Site-directed mutagenesis of
pLuc280(III) was performed using the QuikChangeTM
site-directed mutagenesis kit (Stratagene, La Jolla, CA). Mutagenic primers used for making the pLucBS5B/mt1-mt10 series are listed in
Table I. All constructs were verified by
sequencing.
To construct a murine Zf9 expression plasmid, the murine
Zf9 was amplified with the 5' primer CPBP/5'
(5'-GCATGAAACTTTCACCTGCG-3') and the 3' primer CPBP/3'
(5'-CTCTGCTCCTTCAGAGGTGC-3') using pZL1/Zf9 (a gift of Dr. Rika
Wakao of the Helix Institute) as a template. The amplified 1.0-kb
fragment was subcloned into pT7blueT-Vector (Novagen, Madison, WI) to
make pT7/Zf9. To construct the GST-tagged Zf9 expression
plasmid pGST/Zf9, the XhoI-BamHI fragment
of pT7/Zf9 was cloned into
XhoI-BamHI-digested pGEX-5 (Amersham Biosciences).
pCAG/Zf9, a plasmid that allows expression of Zf9 in
mammalian cells, was constructed by subcloning the
SphI-EcoRI fragment of pT7/Zf9 into the
expression vector pCAGGS/2. pCAGGS/2 was constructed by the insertion
of a multicloning site containing SacI, KpnI, SmaI, BclI, EcoRV, NheI,
BstBI, NsiI, and SphI into pCAGGS at the EcoRI site.
Electrophoresic Mobility Shift Assay (EMSA)--
Nuclear
extracts from BALB/c 3T3 cells were prepared by the method as described
in Ref. 16. Briefly, BALB/c 3T3 cells were washed twice with TBS and
then harvested in TBS with a cell scraper. The cell pellets were
resuspended in Buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 1% Nonidet P-40, and 0.5 mM
phenylmethylsulfonyl fluoride) and incubated on ice for 15 min. After
centrifugation, the pellets were resuspended in buffer C (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM
EDTA, 1 mM EGTA, 1 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride) and rocked on ice for 15 min. The nuclear extracts were recovered by centrifugation.
GST-tagged Zf9 was expressed in Escherichia coli BL21
and purified with glutathione-agarose beads as described previously (17). The concentration of the GST fusion proteins eluted from the
glutathione beads was determined by SDS-PAGE followed by Coomassie Blue
staining with known amounts of bovine serum albumin as a standard.
The DNA probes BS-1 to 9 and EP-1 to 7 were prepared by PCR with
specific primers (Table II). The
sequences of the oligonucleotide probes BS5-A to E and EP7-A to G are
indicated in Table III. All probes were
labeled at the 5' end with [
-32P]ATP by T4
polynucleotide kinase (New England Biolabs Inc., Beverly, MA).
EMSA were performed in a 10-µl final volume containing 10 mM Tris-HCl (pH 7.5), 1 mM MgCl2,
0.5 mM dithiothreitol, 50 mM NaCl, 12%
glycerol, and 1 µg of poly(dI-dC). The binding reaction was carried
out with 10 µg of nuclear extract and ~1 pmol of
32P-labeled probe at room temperature for 30 min. Unlabeled
probes or antibodies were added to the reaction mixture 30 min before the addition of 32P-labeled probes. Probes bound to
proteins were separated on 4% nondenaturing polyacrylamide gels in
0.25× TBE at 250 V for 2.0 h.
One-hybrid Screening--
One-hybrid screening was carried out
essentially as described (18, 19). Four repeats of the BS5-B sequence
from the hsp47 first intron or the EP7-D sequence from the
second intron were cloned into the BglII site of pEHEL2
(19); these plasmids were designated as pEHEL/BS5-B and pEHEL/EP7-D,
respectively. Plasmids were linearized by digestion with
NcoI and integrated into the his3
yeast strain KMY1015 (18). The resulting yeast strains were transformed
with a multicopy plasmid DNA library containing mouse 11-day-old embryo
cDNAs fused to the transcription activation domain of Gal4p
(Clontech, Palo Alto, CA). Transformants were plated on medium lacking histidine and containing 1 mM
3-aminotriazole. After 4 days culture at 30 °C, His+ colonies were
inoculated into liquid medium, and plasmid DNA was extracted. Following
re-amplification in E. coli, the nucleotide sequence of
each clone was determined.
DNA Affinity Precipitation Assay--
Nuclear extracts from
BALB/c 3T3 cells were prepared by the same procedure as for EMSA. The
biotinylated DNA probes BS5-B and EP7-D were made by PCR with a
5'-biotinylated primer. Probe (1 µg) was added to nuclear extracts
(100 µg) containing poly(dI-dC) (15 µg) and the mixture was
incubated on ice for 30 min. Streptavidin-Dynabeads (Dynal, Great Neck,
NY) were added with mixing by rotation for 30 min at 4 °C. The
Dynabeads were collected with a magnet and washed twice with buffer.
The trapped protein was analyzed by SDS-PAGE followed by immunoblot
analysis with an anti-Zf9 antibody (Santa Cruz Biotechnology,
Santa Cruz, CA).
Chromatin Immunoprecipitation Assay--
Chromatin
immunoprecipitation assays were performed using a chromatin
immunoprecipitation assay kit (Upstate Biotech, Lake Placid, NY)
according to the manufacturer's instructions. Briefly, BALB/c 3T3
cells were fixed with 1% formaldehyde for 15 min at 37 °C. Cell
pellets were resuspended in SDS lysis buffer containing protease
inhibitors and sonicated three times for 10 s. Cell lysates were
collected by centrifugation. An aliquot of the lysate (10 µl) was
reserved as a control for amplification by PCR. The remainder was
incubated overnight at 4 °C in CHIP dilution buffer containing protease inhibitors with 5 µl of anti-Sp2, -Sp3, and -Zf9
antibodies (Santa Cruz Biotechnology). Immune complexes were recovered
by the addition of 60 µl of salmon sperm DNA and a protein A-agarose bead suspension, followed by incubation at 4 °C for 2 h. The
beads were washed for 5 min each with 1 ml of low and high salt buffer, then with 1 mM EDTA, Tris-HCl (pH 8.1) containing LiCl and
finally with TE buffer. The immune complexes were eluted by incubation with 1% SDS plus 100 mM NaHCO3. After the
addition of NaCl, the eluates were heated at 65 °C for 4 h to
reverse the cross-linking of DNA by formaldehyde. DNA was recovered by
proteinase K treatment followed by phenol-chloroform extraction and
ethanol precipitation. The resulting pellets were resuspended in 50 µl of TE. Quantitative PCR was carried out for 35 cycles using 5 µl
of sample DNA. PCR products were separated on 10% nondenaturing
polyacrylamide gels in 1× TBE at 120 V for 1.0 h.
 |
RESULTS |
Identification of cis-Acting Elements in HSP47 Introns That
Activate Expression--
In a previous study, Hirata et al.
(15) reported that a 280-bp region of the promoter upstream of the
transcriptional start site is necessary for basal level expression of
hsp47 in murine cells. However, the cell type-specific
expression of hsp47 could not be attributed to this promoter
region alone. Hirata et al. (15) also showed that the first
two introns, located upstream of the translation initiation site, are
necessary in addition to the 280-bp promoter region for the
tissue-specific expression of hsp47. Considering these
previous results, we made systematic deletion constructs fused to the
luciferase gene to identify the cis-acting element(s) in the
first and the second introns that are responsible for the constitutive
expression of hsp47. Luciferase reporter analysis was
performed after transfecting these deletion constructs into BALB/c 3T3
cells; the results of these experiments are shown in Fig.
1.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
The effect of deletions in the intron region
of the hsp47 gene on the expression of luciferase
activity in BALB/c 3T3 cells. Constructs with deletions of the
intron region are shown at the left. These constructs were
transfected into BALB/c 3T3 cells with -actin-galactosidase as an
internal control for transfection efficiency, and luciferase activity
was normalized to -galactosidase activity. The relative luciferase
activity was determined by comparing the activity of each construct
with that of pLuc280(III). Error bars represent the
mean ± S.D. of at least three experiments in duplicate.
|
|
As reported previously, full activity was observed for the pLuc280(III)
construct, which contains the first and second introns in addition to
the 280-bp promoter region, upon transfection into BALB/c 3T3 cells,
whereas modest luciferase activity was observed for a pLuc280 construct
without introns (Fig. 1). pLuc280(III) derivatives with 500- and 480-bp
deletions of the first and second introns (pLuc
BS and pLuc
EPm,
respectively) had levels of luciferase activity that were half that of
pLuc280(III), if the activity of pLuc280 is considered as the basal
level of activity. When both regions were simultaneously deleted, the
activity of the resulting construct (pLuc
PsPm) was equivalent to the
basal activity of pLuc280. From the observation that the activity of
pLuc
SE was the same as that of pLuc280(III), we conclude that the
500-bp sequence (BS-500) in the first intron and the 480-bp sequence (EPm-480) in the second intron are necessary for the activation of
hsp47 transcription in BALB/c 3T3 cells.
To further analyze the cis-acting elements in the first and
the second introns that are responsible for hsp47
expression, we carried out gel mobility shift analysis (EMSA) using
overlapping PCR-amplified fragments that collectively cover the two
introns (Fig. 2A). Incubation
of [32P]phosphate-labeled probes with BALB/c 3T3 nuclear
extracts produced bands of reduced mobility as seen by EMSA (Fig. 2,
B and C). The specificity of the alterations in
band mobility was tested by the addition of an excess of unlabeled
probe. Among the fragments of reduced mobility, two bands that were
produced by the incubation of extracts with the BS-5 probe were of the
same size as two bands produced by incubation with the EP-7 probe (Fig.
2, B, lane 10, and C, lane
14, indicated by arrows). In addition, the two
BS-5-specific bands disappeared when not only unlabeled BS-5 but also
unlabeled EP-7 probes were added as competitors (Fig. 2D,
indicated by arrows). The similar EP-7-specific bands were
also lost when either EP-7 or BS-5 was added as a competitor. No other
competitor fragment (BS-1 to BS-9 and EP-1 to EP-7) had this effect
(data not shown).

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 2.
EMSA using various constructs as probes in
the first and second introns. A, DNA probes used for EMSA
were amplified by PCR using the primers listed in Table II. The length
of each probe is between 100 and 120 bp. B and C,
nuclear extracts from BALB/c 3T3 cells (10 µg) were incubated with
32P-labeled probes specific to the first intron (BS-1 to
BS-9, B) or to the second intron (EP-1 to EP-7,
C), in the presence or absence of a 100-fold molar excess of
unlabeled probe. Arrows indicate two bands commonly detected
for extracts containing the BS-5 or EP-7 probe. D, nuclear
extracts were incubated with 32P-labeled BS-5 (lanes
1-3) or EP-7 (lanes 4-6) in the presence of an excess
of unlabeled BS-5 (lanes 2 and 5) and EP-7
(lanes 3 and 6). The two arrows
indicate protein-DNA complexes commonly observed for extracts incubated
with the BS-5 or EP-7 probe.
|
|
To further define the cis-acting elements in the region
covered by the BS-5 (100 bp) and EP-7 (120 bp) probes that are
responsible for hsp47 expression in BALB/c 3T3 cells, a
series of 30-bp probes that collectively covers the BS-5 and EP-7
regions was synthesized as shown in Fig.
3A for use in EMSA. Fig.
3B clearly shows that incubation of nuclear extracts with
both the BS5-B and EP7-D probes results in the formation of similar
DNA-protein complexes (lanes 2 and 9,
arrows). Interestingly, these bands could be eliminated by
the presence of either of the unlabeled oligonucleotides; the band
shift observed for the 32P-labeled BS5-B probe could be
suppressed by the presence of an excess of the unlabeled BS5-B as well
as of the EP7-D probes (Fig. 3C, lanes 2 and
4). The bands that were produced by incubation of extracts
with EP7-D also did not appear in the presence of unlabeled BS5-B
(lane 7). Other competitors, including BS5-C and EP7-E, did
not interfere with band mobility (Fig. 3C, lanes
3, 5, 8, and 10). These results
indicate that BS5-B and EP7-D share an element(s) that is
recognized by the same transcription factor(s).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 3.
EMSA using various constructs covering BS-5
and EP-7 regions as probes. A, DNA probes used for EMSA. The
sequences of all probes, the lengths of which are between 30 and 35 bp,
are indicated in Table III. B, nuclear extracts from BALB/c 3T3
cells (10 µg) were incubated with 32P-labeled DNA probes
as shown in A. Arrows indicate the two major
bands detected for incubation of extracts with the BS5-B or EP7-D
probe. C, a competition experiment in which nuclear extracts
were incubated with 32P-labeled BS-5 (lanes
1-5) or EP-7 (lanes 6-10) in the presence of
unlabeled BS5-B (lanes 2 and 7), BS5-C
(lanes 3 and 8), EP7-D (lanes 4 and
9), or EP7-E (lanes 5 and 10).
|
|
To identify the core cis-acting elements that activate
hsp47 expression in BALB/c 3T3 cells, we systematically
introduced 4-bp mutations into the BS5-B and EP7-D DNA fragments as
shown in Fig. 4A and performed
EMSA using 32P-labeled BS5-B and EP7-D probes in the
presence of an excess of each mutated construct as a competitor (Fig.
4B). For the 32P-labeled BS5-B probe, the two
mobility shifted bands depicted by arrows disappeared when
the unlabeled competitors BS5-B/mt-4, mt-5, and mt-6 were present,
indicating that the mutated sites are not necessary for transcription
factor binding. In contrast, these shifts in mobility were not affected
by the presence of the competitors BS5-B/mt-1, mt-2, and mt-3. These
results indicate that a 12-bp sequence (GAGGCCACACCC, Fig.
4A) in the BS5-B element is necessary for transcription
factor binding. Similar experiments were performed with mutated EP7-D
constructs (Fig. 4B). For EP7-D, the presence of the
competitors EP7-D/mt-2 and mt-6 caused the mobility shifted bands
indicated by arrows to disappear (Fig. 4B,
lanes 10 and 14). However, the mutant probes
EP7-D/mt-1, mt-3, mt-4, and mt-5 had no effect on the mobility of the
shifted bands. Thus, a 10-bp sequence (GCCCCTCCCA) in the EP7-D element
was identified as necessary for transcription factor binding.
Interestingly, the 12-bp sequence in the BS5-B element and the 10-bp
sequence in the EP7-D element are similar and can be characterized as
GC-rich, as shown in Fig. 4C. It is noteworthy that the band
indicated by an asterisk in Fig. 4B disappeared
when the competitor BS5-B/mt-1 was present (lane 2),
suggesting that this DNA-protein complex contains a protein different
from that in the complexes indicated by the arrows and that
this protein binds to the CCACACCC motif of the 12-bp sequence in the
BS5-B element (see below).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 4.
Mutation analysis of the BS5-B and EP7-D
elements in EMSA. A, site-directed mutagenesis of
oligonucleotides used as competitors in EMSA. Dotted lines
indicate unmutated nucleotides. The core sequences are shown in
bold. B, nuclear extracts from BALB/c 3T3 cells were
incubated with 32P-labeled BS5-B (lanes 1-7) or
EP7-D (lanes 8-14) in the presence of unlabeled
oligonucleotides derived by site-directed mutagenesis. Two major bands
of reduced mobility are indicated by arrows. The
asterisk indicates another mobility-shifted band (see text).
C, the core binding sequences of the BS5-B and EP7-D
elements are similar, as shown by nucleotides marked in
bold.
|
|
To verify that these two elements, which we assume are core sequences
for transcription factor(s) binding, are also necessary for the
transcriptional activation of hsp47 in BALB/c 3T3 cells, we
performed luciferase reporter assays by transfecting a series of
reporter gene constructs with 2-bp mutations in the BS5-B element (Fig.
5). The pLuc
BS, pLuc
BS-5, and
pLuc
BS5-B deletion constructs showed reduced luciferase activities
as compared with pLuc280(III). This result suggested that the BS5-B
30-bp region is necessary for the full activation of the reporter gene.
The mutant constructs pLucBS5-B/mt-3 to mt-8 exhibited reductions in
luciferase activities similar to those of pLuc
BS, pLuc
BS-5, and
pLuc
BS5-B. Other reporter constructs, including pLucBS5-B/mt-1,
mt-2, mt-9, and mt-10 showed luciferase activities comparable with that
of pLuc280(III). Thus, the 12-bp sequence (GAGGCCACACCC) is a core
element necessary for the activation of the reporter gene in BALB/c 3T3
cells in combination with the 280-bp promoter region. This core
sequence is the same as that identified by EMSA (Fig. 4). By a similar analysis of luciferase reporter constructs with systematic mutations in
the EP7-D region, we also confirmed that the 10-bp sequence identified
by EMSA is necessary for transcriptional activation of the reporter
gene in BALB/c 3T3 cells (data not shown).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 5.
The effect of mutations in the BS5-B core
sequence on luciferase reporter activity. Deletions of sequences
in the first intron and site-directed mutagenesis were performed as
described under "Experimental Procedures." Dotted lines
indicate unmutated nucleotides. The core sequences are shown in
bold. Constructs were transfected into BALB/c 3T3 cells and
assayed for luciferase activity. Luciferase activity was normalized to
-galactosidase activity. Error bars represent the
mean ± S.D. of at least three experiments in duplicate.
|
|
Identification of Transcription Factors in a Yeast One-hybrid
Screen--
To identify the transcription factors that bind to the
core sequences (the 12-bp sequence in the BS5-B fragment and the 10-bp sequence in the EP7-D fragment) and activate hsp47
expression, we performed a yeast one-hybrid screen using constructs
containing a quadruplication of the BS5-B or EP7-D core sequences as
baits. We screened a total of 1.2 × 107 independent
clones from an 11-day embryonic mouse cDNA library and obtained 23 positive clones when the BS5-B repeat was used as the bait (Table
IV). No positive clones were obtained
from 1.0 × 107 independent clones screened from the
same cDNA library when the EP7-D repeat was used as the bait.
Sequencing of all the positive clones identified as interacting with
the BS5-B repeat revealed that they encoded several members of the
KLF family, KLF-6 (Zf9/CPBP), KLF-1 (EKLF), KLF-3 (BKLF),
and KLF-4 (GKLF) in the order of the numbers of positive clones
obtained (Table IV).
KLFs are DNA-binding transcriptional regulators that play diverse roles
during differentiation and development (20, 21). They form a subset of
the broad class of Cys2/His2 zinc
finger-containing proteins that bind to DNA via their C-terminal ends.
KLFs reportedly bind to the consensus sequence CACCC, which is found in
the 12-bp core sequence of the BS5-B element (Table IV). The EP7-D
element also contains similar sequences (GCCCC and CTCCC) within the
10-bp core sequence (Fig. 4C). However, EP7-D does not
contain the KLF consensus binding sequence, which may explain why no
KLF family genes were identified in the yeast one-hybrid screen when
the EP7-D repeat was used as a bait.
KLF-1 has been reported to regulate globin and other erythroid
cell-specific gene expression (22), and KLF-4 is specifically expressed
in lung, testis, skin, and thymus (23). KLF-3 is reported to be a
negative regulator (24). Interestingly, KLF-6, also called
Zf9/CPBP, is reported to positively regulate the expression of
collagen
1(I) (25) and the TGF-
and TGF-
receptors in the
fibrosis (26), and it appears to be up-regulated during the progression
of fibrosis (25). In addition, Zf9/CPBP mRNA has been
observed only in hsp47-expressing cells such as BALB/c 3T3
and HeLa cells (data not shown). Therefore, we have focused on the role
of Zf9 in the activation of hsp47 transcription.
Involvement of Zf9 in the Activation of HSP47 Expression in
BALB/c 3T3 Cells--
Because Zf9 was cloned in a
yeast one-hybrid screen using the BS5-B repeat as a bait, the direct
binding of Zf9 to the BS5-B element was examined in
vitro by EMSA. Although supershift analysis using an
anti-Zf9 antibody followed by EMSA would be the most efficient
way to examine the binding of endogenous Zf9 to this sequence,
the Zf9 antibody currently available was ineffective for this
purpose. To overcome this problem, we performed a DNA affinity
precipitation assay. In this method, a protein-DNA complex is isolated
using a specific biotinylated oligonucleotide probe, and bound proteins
are detected by immunoblot analysis with a specific antibody. The
biotinylated BS5-B element was incubated with BALB/c 3T3 nuclear
extracts, and DNA-protein complexes were isolated with
streptavidin-conjugated magnet beads. These complexes were then
examined by immunoblotting using an anti-Zf9 antibody. Zf9 in BALB/c 3T3 nuclear extracts (Fig.
6A, lane
2) was recovered in the precipitate fraction with biotinylated
BS5-B (Fig. 6A, lane 4). This result suggests
that endogenous Zf9 bind to the BS5-B element.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 6.
In vitro binding assay of
Zf9 to the BS5-B element. A, DNA affinity
precipitation assay of biotinylated BS5-B. Nuclear extracts prepared
from BALB/c 3T3 cells were incubated with biotinylated BS5-B and
protein-DNA complexes were isolated using Dynal magnet beads. Proteins
bound to BS5-B were subjected to immunoblot analysis using an
anti-Zf9 antibody. C.E., cell extracts (10 µg);
N.E., nuclear extracts (10 µg); Sup,
flow-through fraction; ppt, fraction bound to the BS5-B
element. B, EMSA assay of the GST/Zf9 fusion protein.
GST (lanes 1-4) and GST/Zf9 (lanes 5-8)
were purified as described under "Experimental Procedures."
Recombinant proteins (weight in µg is shown at top of
lanes) were incubated with 32P-labeled BS5-B
(lanes 1-8) and separated on a nondenaturing 4%
polyacrylamide gel. The two major bands indicated by a
bracket are supershifted by the presence of the anti-GST
antibody (Ab), as indicated by the arrow
(lane 8). C, GST/Zf9 (2 µg) was
incubated with 32P-labeled BS5-B (lanes 1-8) in
the presence of unlabeled oligonucleotides derived by site-directed
mutagenesis shown in Fig. 4A.
|
|
GAGGCCACACCC was identified as a core sequence by mutational analysis
combined with EMSA (Fig. 4B) and by luciferase reporter analysis (Fig. 5). EMSA was performed using the BS5-B probe in the
presence of varying amounts of GST-tagged recombinant Zf9 to
confirm the direct binding of Zf9 to the BS5-B core sequence. As
shown in Fig. 6B, the incubation of GST-tagged Zf9
with the 32P-labeled BS5-B probe resulted in a
dose-dependent manner the appearance of two bands of
reduced mobility. Both of these bands were supershifted by the addition
of anti-GST antibody to the incubation mixture (Fig. 6B,
lane 8). GST alone did not bind to the BS5-B probe. The more
slowly migrating of the two shifted bands was likely produced by the
dimerization of GST. To determine the binding sequence of Zf9
within the BS5-B element, we performed EMSA in the presence of mutant
versions of BS5-B as competitors. The binding of recombinant
GST-Zf9 to the BS5-B probe was not inhibited by the presence of
the BS5-B/mt-2 (GAGGAACAACCC) (Fig. 6C,
lane 4) and mt-3 (GAGGCCACCAAA) mutant probes
(Fig. 6C, lane 5), whereas the mutants BS5-B/mt-1
(TCTTCCACACCC) did interfere with binding (Fig.
6C, lane 3). This suggests that Zf9 does
not bind to the 5' upper portion of this core sequence. In addition, the lower band indicated by the asterisk in Fig.
4B disappeared when BALB/c 3T3 nuclear extracts were
incubated with 32P-labeled BS5-B in the presence of
BS5-B/mt-1 (Fig. 4, lane 2), suggesting that this band might
represent Zf9 bound to the core sequence of the BS5-B element.
In considering these results, we speculated that factors other than
Zf9 might bind to this 5'-upper portion in the 12-bp sequence
(GAGGCCACACCC) of the BS5-B element. This upper portion
contains a GC-rich sequence, which is known to be a possible binding
site for proteins in the Sp1 family (27). Furthermore, these proteins
are reported to cooperate with members of the KLF family in activating
the transcription of target genes (see "Discussion").
To address whether an Sp1 protein binds to the upper sequence of this
core sequence, we next performed EMSA using 32P-labeled
BS5-B as the probe and antibodies against specific Sp1 proteins. Each
of the two major bands depicted by arrows was supershifted in the presence of the anti-Sp2 antibody (Fig.
7, lane 3), and the mobility
of the lower band was also affected by the presence of anti-Sp3
antibody (lane 4). Antibodies against Sp1 and Sp4 had no
effect on probe mobility (lanes 2 and 5). These
results, combined with those shown in Fig. 4B, suggest that
Sp2 and/or Sp3 binds to the 5'-upper portion (GAGGCCA) of the 12-bp
core sequence in the BS5-B element. Supershift analysis with the EP7-D probe revealed that Sp2 and Sp3, but not Sp1 and Sp4, also bind to the
EP7-D element, producing the same shifted band as seen by EMSA (Fig.
7). The band depicted by an asterisk was not supershifted by
the presence of antibodies to Sp1-Sp4 (Fig. 7). This result is
consistent with the proposal that this band represents a complex of
Zf9 and the BS5-B core sequence. Thus, we suggest that
KLF-6/Zf9 binds to sites distinct from those bound by Sp2 and/or
Sp3 within the core sequence of the BS5-B element.

View larger version (91K):
[in this window]
[in a new window]
|
Fig. 7.
Interaction of Sp1 family proteins with the
BS5-B and EP7-D elements. Nuclear extracts from BALB/c 3T3 cells
(10 µg) were incubated with 32P-labeled BS5-B
(lanes 1-5) and EP7-D (lanes 6-10) in the
presence of anti-Sp-1 (lanes 2 and 7), -Sp2
(lanes 3 and 8), -Sp3 (lanes 4 and
9), or -Sp4 (lanes 5 and 10)
antibodies. The brackets show supershifted bands.
|
|
To examine whether these transcription factors bind to the BS5-B core
sequence in vivo, we next performed a CHIP assay using anti-Sp2, anti-Sp3, and anti-Zf9 antibodies. BALB/c 3T3 cells were fixed with formaldehyde and sonicated in SDS lysis buffer to
fragment the DNA to an average size of 200 bp. Protein-bound DNA
fragments were precipitated with antibodies and amplified using the
BS5-B and EP7-D primer sets. Fig. 8 shows
that DNA fragments precipitated with the anti-Sp2 and anti-Sp3
antibodies could be amplified with both the BS5-B and EP7-D primer
sets, whereas those precipitated with control IgG could not be
amplified with either set. DNA fragments precipitated with the
anti-Zf9 antibody also could be amplified with the BS5-B primer
set, but not with the EP7-D primer set (Fig. 8). This result clearly
indicates that in vivo, Sp2 and Sp3 bind to both BS5-B and
EP7-D but Zf9 binds only to BS5-B.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 8.
Binding of endogenous Zf9, Sp2, and
Sp3 proteins to the BS5-B and EP7-D elements in
vivo. CHIP analysis was performed to monitor the
in vivo binding of the endogenous Zf9, Sp2, and Sp3
proteins. Protein-DNA complexes were fixed with formaldehyde and
isolated by immunoprecipitation with control IgG (lanes 4 and 11), anti-Sp2 (lanes 5 and 12),
-Sp3 (lanes 6 and 13), or -Zf9
(lanes 7 and 14) antibodies. PCR was performed on
immunoprecipitated DNA with primers specific for the BS5-B (lanes
2-7) or EP7-D (lanes 9-14) elements. Aliquots of
chromatin prepared before immunoprecipitation (C,
lanes 2 and 9) or without antibody (N,
lanes 3 and 10) were also analyzed. pBR322
MspI fragments were used as molecular weight markers
(lanes 1 and 8).
|
|
Finally, we examined with the luciferase reporter assay whether
exogenously expressed Zf9 activates the transcription of
hsp47. An expression vector containing Zf9 driven by
the CAG promoter was transiently transfected into BALB/c 3T3 cells
together with the luciferase reporter constructs shown in Fig. 1.
Exogenously transfected Zf9 enhanced the luciferase activity of
the pLuc280(III) construct by more than 3-fold (Fig.
9). However, the levels of activation of
the reporter constructs that lack the BS5-B sequence in the first
intron, such as pLuc
BS-5, pLuc
BS5-B, and pLuc
PsPm, were only
about half the level exhibited by pLuc280(III) in the presence of
exogenous Zf9. In contrast, the transfection of Zf9 activated the pLuc
EPm construct, which contains the BS5-B domain in
the first intron, to an extent similar to pLuc280(III) (Fig. 9). These
results clearly indicate that Zf9 activates reporter genes that
contain the BS5-B element. Thus, we conclude that Zf9 is the
transcription factor that specifically binds to the core sequence of
the BS5-B element in the first intron and in collaboration with Sp2
and/or Sp3 activates the expression of hsp47.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 9.
Zf9 transactivates the luciferase
reporter gene through the CACCC sequence in the first intron. The
luciferase reporter constructs shown in Fig. 1 were transfected into
BALB/c 3T3 cells together with the recombinant Zf9 expression
plasmid. Relative luciferase activity was determined by comparing the
activity of each construct with that of pLuc280(III) in the absence of
Zf9. Error bars represent the mean ± S.D. of at
least three experiments in duplicate.
|
|
 |
DISCUSSION |
HSP47 is induced by various stresses including heat shock (28),
and it is the only heat-inducible protein among the stress proteins
residing in the ER of mammalian cells. Other stress proteins in the ER
are induced by the accumulation of unfolded proteins in the ER, a
phenomenon referred to as the unfolded protein response (5). A well
conserved heat shock element in the promoter region at
100 bp is
responsible for the heat inducibility of the hsp47 gene
(7).
On the other hand, the constitutive expression of hsp47 is
always correlated with the constitutive expression of various types of
collagen in several cell lines and tissues; collagen-producing cells
also synthesize hsp47, but the cells that do not produce collagens do not synthesize hsp47 (15). Transgenic mice
harboring a construct consisting of the promoter and the first and
second introns upstream of a lacZ reporter gene express
-galactosidase in those tissues that express hsp47. We
also reported that this constitutive expression of hsp47 is
regulated not only by the promoter region but also by the first intron
of the hsp47 gene in vitro. In the present study,
we showed that in addition to cis-acting elements in the
promoter and the first intron, the second intron is also involved in
regulating hsp47 constitutive expression. Here, we
identified two elements, BS5-B and EP7-D, in the first and second
introns, respectively, which are necessary for the expression of
hsp47 in BALB/c 3T3 cells. We also identified in a yeast
one-hybrid screen four Kruppel-like factors (KLF family proteins) as
proteins that bind to the BS5-B element in the first intron, but not to
the EP7-D element in the second intron. Among KLF family proteins,
Zf9 was reported to activate the expression of various genes,
including type I collagen, TGF-
, and the TGF-
receptor, which are
associated with the progression of hepatic fibrosis (25, 26). We
confirmed in this study that transfected Zf9 activates the
expression of a simultaneously transfected reporter gene under the
control of the BS5-B element and the 280 bp promoter region.
KLF family proteins are characterized by a highly conserved C-terminal
DNA binding domain containing three zinc finger motifs that recognize
the sequence CACCC (20, 21). We showed by EMSA that Zf9 binds to
the CACCC motif in the core sequence of the BS5-B element. However, the
EP7-D element in the second intron does not have the CACCC motif, and
we showed by CHIP analysis that Zf9 does not bind this element
(Fig. 8). This result is consistent with our failure to identify any
members of the KLF family in a yeast one-hybrid screen using EP7-D as a
bait. This was also confirmed by an analysis of luciferase reporter
activity after the transfection of Zf9 cDNA into BALB/c 3T3
cells (Fig. 9). Transfected Zf9 up-regulated luciferase activity
to levels 3-fold greater than observed for the pLuc280(III) construct.
The pLuc
EPm construct, which lacks the EP7-D element, was
up-regulated to the same extent as the pLuc280(III) construct by
transfected Zf9, which suggests that the EP7-D element is not
involved in Zf9-mediated transcriptional activation. We have
first demonstrated here that Zf9 trans-activates gene expression
by interacting with the cis-acting elements in the intron region.
In contrast, an ~2-fold increase in the level of expression was
observed in cells co-transfected with Zf9 and the pLuc
BS-5, pLuc
BS5-B, and pLuc
PsPm constructs (Fig. 9), which do not contain the CACCC motif. This up-regulation might be because of the binding of
overexpressed Zf9 to the promoter region of the hsp47
gene. In fact, we confirmed by EMSA that a GST/Zf9 fusion
protein binds to the GC-rich sequence, a putative Sp1 binding site, in
the hsp47 promoter (data not shown). However, CHIP analysis
using anti-Zf9 antibody indicated that endogenous Zf9
does not bind to the Sp1 site in the hsp47 promoter in
BALB/c 3T3 cells, suggesting that activation by endogenous Zf9
does not involve the Sp1 binding site in vivo.
Among the KLF family proteins that were isolated in this study by yeast
one-hybrid screening, KLF-3 is reported to have a repressor activity
that depends on the recruiting of CtBP2, a general co-repressor
protein, to the transcription factor complex (24). Because we aimed to
identify activator proteins in this study, we did not examine the
influence of KLF-3 on the transcription of hsp47. However,
it should be necessary to examine whether KLF-3 is involved in the
repression of hsp47 expression in hsp47
nonproducing cells in the future. KLF-1 is reported to activate the
-globin gene and other erythroid cell lineage-specific genes in
human and mouse by binding to the CACCC motif in the promoters of these genes (22). KLF-4 is expressed mainly in the gastrointestinal tract,
but transcript is also detected in the lung, testis, skin, and thymus
(23). This protein activates the expression of CYP1A1 (29), a
cytochrome P-450 drug-metabolizing enzyme, keratin 4 (30), keratin 19 (31), cyclin D1 (32), and p21WAF/Cip1 (33), a
cyclin-dependent kinase inhibitor. KLF-4 was shown to
co-activate the human keratin 4 gene through an interaction with
Zf9/KLF-6 (30). Although Zf9 was clearly shown in this study to be involved in the activation of hsp47 expression
in BALB/c 3T3 cells, a possible involvement of KLF-4 in cooperation with Zf9/KLF-6 might be an interesting issue to be examined in relation to the regulation of the hsp47 gene in the future.
The C-terminal zinc finger motif of KLF family proteins is also found
at the C termini of Sp1 family proteins, which can bind the GC box.
Thus, Sp1 and KLF family proteins, both of which belong to the same
superfamily, recognize similar GC-rich DNA elements (34, 35). The Sp3
protein was previously reported to bind to a GC-rich site at
210 bp
in the promoter of hsp47 and to be required for basal levels
of reporter activity in a luciferase assay in both
hsp47-producing and nonproducing cells (15). CHIP analysis
using an anti-Sp3 antibody showed that Sp3 binds to this GC-rich
sequence in
vivo.2
The involvement of Sp1 family proteins in the transcriptional
regulation of collagen has been reported. Both the Sp1 binding site in
the promoter region and the first intron are necessary for the
up-regulation of COL2A1 transcription in cartilage (36). Sox9 has been shown to trans-activate the COL2A1 gene by
binding to sequences in the intron (37). Sp1 also binds to one of the two GC boxes in the type II collagen promoter, and it also interacts with a zinc finger protein, CIIZFP, that is bound to the first intron,
resulting in the activation in chondrocytes of the type II collagen
gene (38). Sox9 is also reported to activate the COL11A2
gene by binding to the CTCAAAG motif in the first intron and
interacting with the promoter region (39).
In this study, we revealed that two Sp1 family proteins, Sp2 and Sp3,
bind to the BS5-B and EP7-D elements in the first and second introns,
respectively. Vergeer et al. (40) reported that the type I
collagen gene has several cis-acting regulatory elements, including AP2 binding sites in the promoter and Sp1 binding site clusters in the first intron. Electron microscopic analysis showed that
heterologous and homologous protein-protein interactions involving Sp1
and AP2 bring the promoter and the intron into close contact,
facilitating transcription initiation. Recently, the importance
of the Sp1 binding sites in the first intron of the type I collagen
gene was revealed by the observation that the polymorphic substitution
of G by T in the Sp1 binding site in the first intron of the
COL1A1 gene causes a reduction in bone density in the
osteoporosis by reducing the expression of its mRNA (41).
Sp1 family proteins are ubiquitously expressed whereas KLF family
proteins are not. Cooperative but distinctive functions between members
of the two families have been shown in various cases in addition to the
activation of the COL1A1 gene and TGF-
and TGF-
receptor genes (25, 26). The core promoter of leukotriene C4 synthase,
which catalyzes the conjugation of glutathione with leukotriene A4 to
form leukotriene C4, is composed of the CACCC motif and a downstream GC
box (42). The basal expression of leukotriene C4 synthase is regulated
by Sp1 bound to the GC box, and cell type-specific expression in THP-1
cells is regulated by both Sp1 and Zf9 bound to the CACCC motif.
The tissue-specific expression of the laminin
1 chain and keratin 19 genes is also regulated by cooperation between KLF-4 and Sp1 (31, 43).
Whereas it is not clear at present whether Zf9/KLF-6 is involved
in the tissue-specific expression of hsp47, the observations
that Sp2 and/or Sp3 bind to three sites in the promoter, the first and second introns and that Zf9 binds to the cis-acting
element in the first intron, resulting in an activation of
hsp47 gene expression in HSP47-producing cells, lead us to
propose Zf9 as the co-activator for the tissue-specific
expression of hsp47.
The expression of HSP47 is dramatically up-regulated in fibrogenic
pathophysiological conditions including liver, lung and kidney fibrosis
(12), keroid (44), systemic fibrosis (45), and atherosclerosis (13),
all of which are characterized by the abnormal accumulation of several
types of collagens, including types I and III, in various tissues.
Interestingly, in the rat model of kidney fibrosis, the transient
down-regulation of hsp47 expression by the administration of
hsp47 antisense oligonucleotides causes a reduction in the
progression of fibrosis as well as a reduction in the accumulation of
HSP47 and types I and IV collagens in mesangial cells (14). Thus, the
regulation of hsp47 is interesting and important from the
therapeutic point of view and is highly relevant for future studies of
fibrogenic diseases.
 |
ACKNOWLEDGEMENT |
We thank Dr. K. Mori for providing the plasmid
vector yeast strain used for one-hybrid screening.
 |
FOOTNOTES |
*
This work was supported by grants from the Ministry of
Education, Culture, Sports, Science and Technology of Japan (to N. H. and K. N.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Molecular
and Cellular Biology, Institute for Frontier Medical Sciences, Kyoto
University, Sakyo-ku, Kyoto 606-8397, Japan. Tel.: 81-75-751-3848; Fax:
81-75-751-4646; E-mail: nagata@frontier.kyoto-u.ac.jp.
Published, JBC Papers in Press, September 13, 2002, DOI 10.1074/jbc.M208558200
2
K. Yasuda, K. Hirayoshi, H. Hirata, H. Kubota, N. Hosokawa, and K. Nagata, unpublished observation.
 |
ABBREVIATIONS |
The abbreviations used are:
ER, endoplasmic reticulum;
KLF, Kruppel-like factor;
GST, glutathione
S-transferase;
CHIP, chromatin immunoprecipitation;
EMSA, electrophoretic mobility shift assay;
TGF, transforming growth
factor.
 |
REFERENCES |
| 1.
|
Hirayoshi, K.,
Kudo, H.,
Takechi, H.,
Nakai, A.,
Iwamatsu, A.,
Yamada, K. M.,
and Nagata, K.
(1991)
Mol. Cell. Biol.
11,
4036-4044[Abstract/Free Full Text]
|
| 2.
|
Satoh, M.,
Hirayoshi, K.,
Yokota, S.,
Hosokawa, N.,
and Nagata, K.
(1996)
J. Cell Biol.
133,
469-483[Abstract/Free Full Text]
|
| 3.
|
Koide, T.,
Takahara, Y.,
Asada, S.,
and Nagata, K.
(2002)
J. Biol. Chem.
277,
6178-6182[Abstract/Free Full Text]
|
| 4.
|
Nagai, N.,
Hosokawa, M.,
Itohara, S.,
Adachi, E.,
Matsushita, T.,
Hosokawa, N.,
and Nagata, K.
(2000)
J. Cell Biol.
150,
1499-1506[Abstract/Free Full Text]
|
| 5.
|
Mori, K.
(2000)
Cell
101,
451-454[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Chapman, R.,
Sidrauski, C.,
and Walter, P.
(1998)
Annu. Rev. Cell Dev. Biol.
14,
459-485[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Hosokawa, N.,
Takechi, H.,
Yokota, S.,
Hirayoshi, K.,
and Nagata, K.
(1993)
Gene (Amst.)
126,
187-193[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Takechi, H.,
Hirayoshi, K.,
Nakai, A.,
Kudo, H.,
Saga, S.,
and Nagata, K.
(1992)
Eur. J. Biochem.
206,
323-329[Medline]
[Order article via Infotrieve]
|
| 9.
|
Nakai, A.,
Satoh, M.,
Hirayoshi, K.,
and Nagata, K.
(1992)
J. Cell Biol.
117,
903-914[Abstract/Free Full Text]
|
| 10.
|
Masuda, H.,
Hosokawa, N.,
and Nagata, K.
(1998)
Cell Stress Chaperones
3,
256-264[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Masuda, H.,
Fukumoto, M.,
Hirayoshi, K.,
and Nagata, K.
(1994)
J. Clin. Invest.
94,
2481-2488[Medline]
[Order article via Infotrieve]
|
| 12.
|
Sunamoto, M.,
Kuze, K.,
Iehara, N.,
Takeoka, H.,
Nagata, K.,
Kita, T.,
and Doi, T.
(1998)
Int. J. Exp. Pathol.
79,
133-140[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Murakami, S.,
Toda, Y.,
Seki, T.,
Munetomo, E.,
Kondo, Y.,
Sakurai, T.,
Furukawa, Y.,
Matsuyama, M.,
Nagate, T.,
Hosokawa, N.,
and Nagata, K.
(2001)
Atherosclerosis
157,
361-368[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Sunamoto, M.,
Kuze, K.,
Tsuji, H.,
Ohishi, N.,
Yagi, K.,
Nagata, K.,
Kita, T.,
and Doi, T.
(1998)
Lab. Invest.
78,
967-972[Medline]
[Order article via Infotrieve]
|
| 15.
|
Hirata, H.,
Yamamura, I.,
Yasuda, K.,
Kobayashi, A.,
Tada, N.,
Suzuki, M.,
Hirayoshi, K.,
Hosokawa, N.,
and Nagata, K.
(1999)
J. Biol. Chem.
274,
35703-35710[Abstract/Free Full Text]
|
| 16.
|
Schreiber, E.,
Matthias, P.,
Muller, M. M.,
and Schaffner, W.
(1989)
Nucleic Acids Res.
17,
6419[Free Full Text]
|
| 17.
|
Asada, S.,
Koide, T.,
Yasui, H.,
and Nagata, K.
(1999)
Cell Struct. Funct.
24,
187-196[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Mori, K.,
Kawahara, T.,
Yoshida, H.,
Yanagi, H.,
and Yura, T.
(1996)
Genes Cells
1,
803-817[Abstract]
|
| 19.
|
Kubota, H.,
Yokota, S.,
Yanagi, H.,
and Yura, T.
(2000)
J. Biol. Chem.
275,
28641-28648[Abstract/Free Full Text]
|
| 20.
|
Turner, J.,
and Crossley, M.
(1999)
Trends Biochem. Sci.
24,
236-240[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Bieker, J. J.
(2001)
J. Biol. Chem.
276,
34355-34358[Free Full Text]
|
| 22.
|
Miller, I. J.,
and Bieker, J. J.
(1993)
Mol. Cell. Biol.
13,
2776-2786[Abstract/Free Full Text]
|
| 23.
|
Shields, J. M.,
Christy, R. J.,
and Yang, V. W.
(1996)
J. Biol. Chem.
271,
20009-20017[Abstract/Free Full Text]
|
| 24.
|
Turner, J.,
and Crossley, M.
(1998)
EMBO J.
17,
5129-5140[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Ratziu, V.,
Lalazar, A.,
Wong, L.,
Dang, Q.,
Collins, C.,
Shaulian, E.,
Jensen, S.,
and Friedman, S. L.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9500-9505[Abstract/Free Full Text]
|
| 26.
|
Kim, Y.,
Ratziu, V.,
Choi, S. G.,
Lalazar, A.,
Theiss, G.,
Dang, Q.,
Kim, S. J.,
and Friedman, S. L.
(1998)
J. Biol. Chem.
273,
33750-33758[Abstract/Free Full Text]
|
| 27.
|
Suske, G.
(1999)
Gene
238,
291-300[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Nagata, K.,
Hirayoshi, K.,
Obara, M.,
Saga, S.,
and Yamada, K. M.
(1988)
J. Biol. Chem.
263,
8344-8349[Abstract/Free Full Text]
|
| 29.
|
Zhang, W.,
Shields, J. M.,
Sogawa, K.,
Fujii-Kuriyama, Y.,
and Yang, V. W.
(1998)
J. Biol. Chem.
273,
17917-17925[Abstract/Free Full Text]
|
| 30.
|
Okano, J.,
Opitz, O. G.,
Nakagawa, H.,
Jenkins, T. D.,
Friedman, S. L.,
and Rustgi, A. K.
(2000)
FEBS Lett.
473,
95-100[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Brembeck, F. H.,
and Rustgi, A. K.
(2000)
J. Biol. Chem.
275,
28230-28239[Abstract/Free Full Text]
|
| 32.
|
Shie, J. L.,
Chen, Z. Y., Fu, M.,
Pestell, R. G.,
and Tseng, C. C.
(2000)
Nucleic Acids Res.
28,
2969-2976[Abstract/Free Full Text]
|
| 33.
|
Zhang, W.,
Geiman, D. E.,
Shields, J. M.,
Dang, D. T.,
Mahatan, C. S.,
Kaestner, K. H.,
Biggs, J. R.,
Kraft, A. S.,
and Yang, V. W.
(2000)
J. Biol. Chem.
275,
18391-18398[Abstract/Free Full Text]
|
| 34.
|
Philipsen, S.,
and Suske, G.
(1999)
Nucleic Acids Res.
27,
2991-3000[Abstract/Free Full Text]
|
| 35.
|
Black, A. R.,
Black, J. D.,
and Azizkhan-Clifford, J.
(2001)
J. Cell. Physiol.
188,
143-160[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Krebsbach, P. H.,
Nakata, K.,
Bernier, S. M.,
Hatano, O.,
Miyashita, T.,
Rhodes, C. S.,
and Yamada, Y.
(1996)
J. Biol. Chem.
271,
4298-4303[Abstract/Free Full Text]
|
| 37.
|
Bell, D. M.,
Leung, K. K.,
Wheatley, S. C., Ng, L. J.,
Zhou, S.,
Ling, K. W.,
Sham, M. H.,
Koopman, P.,
Tam, P. P.,
and Cheah, K. S.
(1997)
Nat. Genet.
16,
174-178[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Savagner, P.,
Krebsbach, P. H.,
Hatano, O.,
Miyashita, T.,
Liebman, J.,
and Yamada, Y.
(1995)
DNA Cell Biol.
14,
501-510[Medline]
[Order article via Infotrieve]
|
| 39.
|
Bishop, C. E.,
Whitworth, D. J.,
Qin, Y.,
Agoulnik, A. I.,
Agoulnik, I. U.,
Harrison, W. R.,
Behringer, R. R.,
and Overbeek, P. A.
(2000)
Nat. Genet.
26,
490-494 |